Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.